Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ Von Hippel Lindau Recombinant Protein Antigen
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP255082PEP
Description
A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human Von Hippel Lindau. Source: E.coli Amino Acid Sequence: RRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAG The Von Hippel Lindau Recombinant Protein Antigen is derived from E. coli. The Von Hippel Lindau Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.Specifications
7428 | |
Von Hippel Lindau Recombinant Protein Antigen | |
PBS and 1M Urea, pH 7.4 | |
elongin binding protein, HRCA1, Protein G7, pVHL, RCA1, VHL1, von Hippel-Lindau disease tumor suppressor, von Hippel-Lindau syndrome, von Hippel-Lindau tumor suppressor | |
Unlabeled | |
100μL | |
E.coli |
>80% by SDS-PAGE and Coomassie blue staining | |
Store at −20°C. Avoid freeze-thaw cycles | |
Blocking/Neutralizing, Control | |
VHL | |
Recombinant Protein Antigen | |
RUO | |
This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51223. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For research use only.
Spot an opportunity for improvement?
Provide Content Correction